Table 2.
Values of TNF- α, IL-6, IL-8, MFI total score and fatigue symptom dimensions in group (A) before and after treatment
| Mean + SD | t-value | Significance | ||
| Before treatment |
After treatment |
|||
| TNF-α (pg/mL) | 6.15 ± 1.63* | 4.37 ± 1.48 | 6.82 | P <0.05 |
| IL-6 (pg/mL) | 6.83 ± 2.15* | 5.04 ± 1.92 | 5.87 | P <0.05 |
| IL-8 (pg/mL) | 14.17 ± 3.93* | 12.03 ± 3.61 | 7.93 | P <0.05 |
| BMI (kg/m2) | 31.65 ± 5.53* | 26.82 ± 4.88 | 7.58 | P<0.05 |
| MFI total score | 55.12 ± 12.94* | 41.11± 13.72 | 6.54 | P <0.05 |
| Fatigue symptom dimensions | ||||
| General fatigue | 13.28± 2.85* | 9.52± 3.61 | 5.43 | P <0.05 |
| Physical fatigue | 12.17 ± 3.16* | 8.74 ± 2.92 | 6.76 | P <0.05 |
| Reduced activity | 11.33± 3.62* | 8.15± 3.43 | 5.81 | P <0.05 |
| Mental fatigue | 9.11±3.72* | 7.54± 3.24 | 6.74 | P <0.05 |
|
Reduced motivation |
9.23± 2.32* | 7.16 ± 3.41 | 5.36 | P <0.05 |
TNF- α: tumor necrosis factor - alpha; IL-6: Interleukin-6; BMI: Body Mass Index; IL-8: Interleukin-8; MFI: Multidimensional Fatigue Inventory;
*
indicates a significant difference between the two groups, P < 0.05.